ArticleCancer gene therapy2022

Intratumoral DNA-based delivery of checkpoint-inhibiting antibodies and interleukin 12 triggers T cell infiltration and anti-tumor response.

Liesl Jacobs et al.PubMed ↗Publisher ↗

No numbers read from the abstract.